Pacific Biosciences of Californ Price Today
Pacific Biosciences of Californ
PACB
Healthcare
$1.78B
💰
Market Cap
0
💸
Price to Earnings
$-1.4
🎉
EPS
+0
🌳
ESG
Consensus Recommendations
Buy Consensus
Buy |
8 |
Strong Buy |
4 |
Hold |
6 |
Sell |
0 |
Strong Sell |
0 |
PACB Price Forecast Target
7.1 👉 20.0 +181%
PACB EPS Forecast
-1.4 👉 -1.0 +-27%
Financials
Profit Margin
-218 %
Revenue Growth
34.1 %
Dividend
$ 0
Held Percent
1.7% - Insiders
97.0% - Institutions
1.3% - Public
Major Fund Holders
-
💰 ARK Investment Management, LLC $249.0M
-
💰 Vanguard Group Inc $307.6M
-
💰 Blackrock Inc. $276.9M
-
💰 Madrone Advisors, LLC $218.3M
-
💰 Nikko Asset Management Americas, Inc. $181.5M
Stock Ideas
David Einhorn Portfolio
David Einhorn is one of the most successful long/short equity hedge fund managers of the past decade. As of July 2013, David Einhorn’s Greenlight Capital has returned 19.5% since its inception in 1996. Greenlight Capital’s market beta is around 0.5,…
Jim Chanos Portfolio
Jim Chanos is a revered figure in the world of portfolio management, known for his expertise in short selling and his pivotal role in uncovering fraud at Enron and WorldCom. Hailing from Milwaukee and a graduate of Yale with an economics degree, Ch…
Nelson Peltz Portfolio
Nelson Peltz is a renowned investor known for his astute investment strategies and activist approach. With a portfolio spanning diverse industries, Peltz strategically targets underperforming companies, advocating for changes that unlock their full …
Chase Coleman Portfolio
Chase Coleman, the young and accomplished founder of Tiger Global, has made a significant impact in the investment world. With initial funding from Julian Robertson, Coleman's Tiger Global Management delivered impressive returns, including a remarka…📮FAQ
Some Frequently Asked Questions.
The Pacific Biosciences of Californ industry is Medical Devices
The Pacific Biosciences of Californ sector is Healthcare
The Pacific Biosciences of Californ forecasted predicted Price to Earnings PE ratio is -7.2
The Pacific Biosciences of Californ Price to Earnings PE ratio is 0
The Market Capitalization of Pacific Biosciences of Californ is $1.78B
There are total of 249789079 float shares with 97.0% held by Institutions and 1.7% held by insiders
The MPacific Biosciences of Californ forecasted Earnings per Share EPS is $-1.0
The Pacific Biosciences of Californ Earnings per Share EPS is -1.4
The Pacific Biosciences of Californ company has $53473000 gross profits with -218 profit margins
The Pacific Biosciences of Californ Earnings Growth is 0% with 0% quarterly earnings growth
The Pacific Biosciences of Californ Revenue is $146136992 with 0.341 revenue growth
The price target for Pacific Biosciences of Californ stock is $20.0 for the high target and $9.0 for the low target
The consensus analyst recommendations for Pacific Biosciences of Californ is Buy, however the decision to buy or sell the stock should be entirely yours, as you are earning your own money and hence responsible on how to allocate and spend them.
The consensus analyst recommendations for Pacific Biosciences of Californ is Buy, with the following breakdown:
- Buy: 8
- Strong Buy: 4
- Hold: 6
- Sell: 0
- Strong Sell: 0
The Beta of Pacific Biosciences of Californ is 1.7
The dividend of Pacific Biosciences of Californ is $0
The dividend yield of Pacific Biosciences of Californ is 0%
The biggest institutional and mutual fund holders of Pacific Biosciences of Californ stock are
- ARK Investment Management, LLC
- Vanguard Group Inc
- Blackrock Inc.
- Madrone Advisors, LLC
The Pacific Biosciences of Californ ESG Score is 0, with the following breakdown:
- E: 0
- S: 0
- G: 0